Clinical Trial

Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma

Study acronym: MesoRT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a monocentric prospective study of radiotherapy using accelerated hypofractionation with Tomotherapy in Malignant Pleural Mesothelioma (MPM) patients after pleurectomy / decortication (P / D) or biopsy. The treatment will be delivered using Tomotherapy, that allows to adopt dose accelerated hypofraction criteria. Treatment duration is 5 consecutive days.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2017-08-29; most recent amendment 2026-01-15.
Status change: Recruiting → Active, Not Recruiting 2026-01-15
Trial Details
NCT Number NCT03269227
Lead Sponsor Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Conditions Malignant Pleural Mesothelioma
Enrollment 30 participants
Start Date 2017-08-14
Primary Completion 2024-04-24 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-01-16